scispace - formally typeset
Search or ask a question
Institution

Roussel Uclaf

About: Roussel Uclaf is a based out in . It is known for research contribution in the topics: Alkyl & Alkoxy group. The organization has 1888 authors who have published 2338 publications receiving 36508 citations.
Topics: Alkyl, Alkoxy group, Aryl, Carbon, Carboxylic acid


Papers
More filters
Patent
08 Apr 1993
TL;DR: The application relates to the products (I): in which: - R represents H, halogen or alkyl which is linear, branched or cyclic, optionally interrupted by one or a number of O, S or N, or R represents optionally substituted aryl or heterocyclic aryls with p = 0 to 6 as mentioned in this paper.
Abstract: The application relates to the products (I): in which: - R represents H, halogen or alkyl which is linear, branched or cyclic, optionally interrupted by one or a number of O, S or N, or R represents optionally substituted aryl, aryloxy or heterocyclic aryl or with p = 0 to 6, or R represents with Ra, Rb and Rc = alkyl or R represents with a and b = H, halogen, OH, alkyl or alkoxy or a and b together form a cycloalkyl and R' has one of the values of R, - R2 and R3 represent H, alkyl or to their process of preparation and to their application as pesticidal agent.

5 citations

Patent
27 Jun 1979
TL;DR: In this paper, the Δ4 -androstenes of the formula ##STR1## were considered and the dotted lines in the A and B rings indicated the optional presence of one or two double bonds in the 1(2) and 6(7)-positions with the proviso that when R1 is methyl, R2 is saturated or unsaturated alkyl and the B ring is saturated, Y is methyl having anti-inflammatory activity and novel intermediates.
Abstract: Novel Δ4 -androstenes of the formula ##STR1## wherein R1 is alkyl of 1 to 3 carbon atoms, Y is selected from the group consisting of hydrogen, fluorine and methyl, R2 is selected from the group consisting of saturated and unsaturated alkyl of 1 to 12 carbon atoms, --CF3, aryl of 6 to 12 carbon atoms and aralkyl of 7 to 12 carbon atoms and the dotted lines in the A and B rings indicate the optional presence of one or two double bonds in the 1(2) and 6(7)-positions with the proviso that when R1 is methyl, R2 is saturated or unsaturated alkyl and the B ring is saturated, Y is methyl having anti-inflammatory activity and novel intermediates.

5 citations

Journal ArticleDOI
M M'Harzi1, F Willig1, C. Bardelay1, A.-M Palou1, C Oberlander1 
TL;DR: The present results show that the alpha 2-adrenergic antagonist RU 52583 possesses cognition-enhancing properties in rats with damage to the septohippocampal system.
Abstract: The anti-amnesic action of RU 52583, an alpha 2-adrenergic receptor antagonist, was evaluated through performance of spatial tasks in a radial maze by rats with N-methyl-D-aspartic acid (NMDA) lesion of the medial septal (MS) nuclei. Memory performance of lesioned or sham-operated rats was evaluated by measuring reference memory as long-term maintenance of an acquired performance and working memory or memory for recent events. The lesion: a produced significant impairments of the animals' memory performance, b) significantly reduced the sodium-dependent high-affinity choline uptake in the hippocampal formation, and c) deeply disrupted cholinergic hippocampal theta waves. Oral administration of RU 52583 at 1 and 2 mg/kg (tested doses: 1-5 mg/kg) prior to performance of the task markedly reduced memory impairments, whereas idazoxan, another alpha 2-adrenergic receptor antagonist, had no effect at tested doses (2-5 mg/kg). Cholinergic drugs--arecoline at 0.1 and 1 mg/kg (tested doses: 0.05-1 mg/kg) and physostigmine at 0.02 and 0.1 mg/kg (tested doses: 1, 2, and 5 mg/kg)-administered intraperitoneally showed a tendency to alleviate memory deficits. The present results show that the alpha 2-adrenergic antagonist RU 52583 possesses cognition-enhancing properties in rats with damage to the septohippocampal system.

5 citations

Patent
08 Jan 1982
TL;DR: In this article, a process for the preparation of products of formula: in which: R1 = H, Alk C1-4 optionally substituted Alkenyl or alkynyl C2-4 R2 = Alk A, B, C, D optionally bear one or more double bonds and are optionally substituted, starting from products comprising at 17 a radical: R3 =H, protective group, by the action of an acetoxylation agent, then of a hydrolysis agent and finally a deacetoxylating agent.
Abstract: The present application relates to a process for the preparation of products of formula: in which: R1 = H, Alk C1-4 optionally substituted Alkenyl or alkynyl C2-4 R2 = Alk C1-4 A, B, C, D optionally bear one or more double bonds and are optionally substituted, starting from products comprising at 17 a radical: R3 = H, protective group, by the action of an acetoxylation agent, then of a hydrolysis agent and finally a deacetoxylation agent.

5 citations


Authors

Showing all 1888 results

NameH-indexPapersCitations
Fernand Labrie11088548308
Lionel H. Opie8451925964
Alain Bélanger7024416469
Michel J. Tremblay5327310485
Pierre Monsan512168049
Samir Z. Zard5057510739
Alejandro Aruffo4712314084
Samuel S.C. Yen47966865
Dominique Maraninchi471888108
Serge Erlinger461528200
Romain Lefebvre402215269
William B. Motherwell393056357
Jean-Pierre Raynaud381045075
André Lemay381144264
Patrick J. Creaven321023435
Network Information
Related Institutions (5)
Merck & Co.
48K papers, 1.9M citations

85% related

Novartis
50.5K papers, 1.9M citations

85% related

Pfizer
37.4K papers, 1.6M citations

84% related

Eli Lilly and Company
22.8K papers, 946.7K citations

84% related

AstraZeneca
23.4K papers, 938.2K citations

82% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20181
20114
20104
20091
20084
20072